Thus, the specific combination of cytogenetic alterations acquired by the CLL-like B-cells may determine, for distinct antigenic stimuli, and specific BCR repertoires, the outcome of the genetically-targeted cell. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.